Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Recommended composition of influenza virus vaccines for use in the 2012–2013 northern hemisphere influenza season.

× No keyword cloud information.

26 in total

1. Immunogenicity and safety of a cell culture-derived inactivated quadrivalent influenza vaccine (NBP607-QIV): A randomized, double-blind, multi-center, phase III clinical trial in adults and elderly subjects.

Authors: Won Suk Choi; Ji Yun Noh; Joon Young Song; Hee Jin Cheong; Seong-Heon Wie; Jin Soo Lee; Jacob Lee; Shin-Woo Kim; Hye Won Jeong; Sook-In Jung; Yeon-Sook Kim; Heung Jeong Woo; Kyung Ho Kim; Hun Kim; Woo Joo Kim
Journal: Hum Vaccin Immunother Date: 2017-04-13 Impact factor: 3.452

2. Severity of the two post-pandemic influenza seasons 2010-11 and 2011-12 in Northern Greece.

Authors: A Melidou; M Exindari; G Gioula; N Malisiovas
Journal: Hippokratia Date: 2013-04 Impact factor: 0.471

3. Influenza vaccine effectiveness in households with children during the 2012-2013 season: assessments of prior vaccination and serologic susceptibility.

Authors: Suzanne E Ohmit; Joshua G Petrie; Ryan E Malosh; Alicia M Fry; Mark G Thompson; Arnold S Monto
Journal: J Infect Dis Date: 2014-11-21 Impact factor: 5.226

4. Molecular surveillance of antiviral drug resistance of influenza A/H3N2 virus in Singapore, 2009-2013.

Authors: Hong Kai Lee; Julian Wei-Tze Tang; Tze Ping Loh; Aeron C Hurt; Lynette Lin-Ean Oon; Evelyn Siew-Chuan Koay
Journal: PLoS One Date: 2015-01-30 Impact factor: 3.240

5. Influenza vaccine effectiveness in preventing inpatient and outpatient cases in a season dominated by vaccine-matched influenza B virus.

Authors: Iván Martínez-Baz; Ana Navascués; Francisco Pozo; Judith Chamorro; Esther Albeniz; Itziar Casado; Gabriel Reina; Manuel García Cenoz; Carmen Ezpeleta; Jesús Castilla
Journal: Hum Vaccin Immunother Date: 2015 Impact factor: 3.452

6. Computational prediction of vaccine strains for human influenza A (H3N2) viruses.

Authors: L Steinbrück; T R Klingen; A C McHardy
Journal: J Virol Date: 2014-08-13 Impact factor: 5.103

7. Enzymatic stability and immunoregulatory efficacy of a synthetic indolicidin analogue with regular enantiomeric sequence.

Authors: Ching-Yun Chang; Chih-Wei Lin; Sheng-Kuo Chiang; Po-Ling Chen; Chiung-Yi Huang; Shih-Jen Liu; Pele Chong; Ming-Hsi Huang
Journal: ACS Med Chem Lett Date: 2013-04-24 Impact factor: 4.345

8. A 2013/2014 northern hemisphere season surface antigen inactivated trivalent influenza vaccine--Assessing the immunogenicity and safety in an open label, uncontrolled study.

Authors: Louise Roggelin; Christof D Vinnemeier; Seetha Meyer; Kai Witte; Lydia Marx; Wiebke Theeß; Gerd D Burchard; Thierry Rolling; Jakob P Cramer
Journal: Hum Vaccin Immunother Date: 2015 Impact factor: 3.452

9. Influenza seasonality and predominant subtypes of influenza virus in Guangdong, China, 2004-2012.

Authors: Jinyan Lin; Min Kang; Haojie Zhong; Xin Zhang; Fen Yang; Hangzhong Ni; Ping Huang; Teng Hong; Changwen Ke; Jianfeng He
Journal: J Thorac Dis Date: 2013-08 Impact factor: 2.895

10. Evolution of the receptor binding properties of the influenza A(H3N2) hemagglutinin.

Authors: Yi Pu Lin; Xiaoli Xiong; Stephen A Wharton; Stephen R Martin; Peter J Coombs; Sebastien G Vachieri; Evangelos Christodoulou; Philip A Walker; Junfeng Liu; John J Skehel; Steven J Gamblin; Alan J Hay; Rodney S Daniels; John W McCauley
Journal: Proc Natl Acad Sci U S A Date: 2012-12-10 Impact factor: 11.205